Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery

Xi Tian, Haydee Lara, Kyle T. Wagner, Srinivas Saripalli, Syed Nabeel Hyder, Michael Foote, Manish Sethi, Edina Wang, Joseph M. Caster, Longzhen Zhang, Andrew Z. Wang

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Radiotherapy is a key component of cancer treatment. Because of its importance, there has been high interest in developing agents and strategies to further improve the therapeutic index of radiotherapy. DNA double-strand repair inhibitors (DSBRIs) are among the most promising agents to improve radiotherapy. However, their clinical translation has been limited by their potential toxicity to normal tissue. Recent advances in nanomedicine offer an opportunity to overcome this limitation. In this study, we aim to demonstrate the proof of principle by developing and evaluating nanoparticle (NP) formulations of KU55933, a DSBRI. We engineered a NP formulation of KU55933 using nanoprecipitation method with different lipid polymer nanoparticle formulation. NP KU55933 using PLGA formulation has the best loading efficacy as well as prolonged drug release profile. We demonstrated that NP KU55933 is a potent radiosensitizer in vitro using clonogenic assay and is more effective as a radiosensitizer than free KU55933 in vivo using mouse xenograft models of non-small cell lung cancer (NSCLC). Western blots and immunofluorescence showed NP KU55933 exhibited more prolonged inhibition of DNA repair pathway. In addition, NP KU55933 leads to lower skin toxicity than KU55933. Our study supports further investigations using NP to deliver DSBRIs to improve cancer radiotherapy treatment.

Original languageEnglish (US)
Pages (from-to)20211-20219
Number of pages9
JournalNanoscale
Volume7
Issue number47
DOIs
StatePublished - Dec 21 2015
Externally publishedYes

ASJC Scopus subject areas

  • Materials Science(all)

Fingerprint

Dive into the research topics of 'Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery'. Together they form a unique fingerprint.

Cite this